Sorrentino Michele, Belpiede Alessandro, Fiorilla Claudio, Mercogliano Michelangelo, Triassi Maria, Palladino Raffale
Department of Public Health, University Federico II - Naples, Italy.
Interdepartmental Research Center in Healthcare Management and Innovation in Healthcare (CIRMIS), Naples, Italy.
Vaccine X. 2024 Aug 3;20:100544. doi: 10.1016/j.jvacx.2024.100544. eCollection 2024 Oct.
The Herpes Zoster (HZ) poses a significant public health threat, leading to morbidity and occasional mortality in unvaccinated adults aged 50 and older. With over 95 % of individuals in this age group globally having prior exposure to Varicella-Zoster Virus, a substantial portion of the world's population is susceptible to developing HZ. Without vaccination, individuals reaching 85 years face a 50 % lifetime risk of HZ. Organizational and logistical barriers further hinder vaccination efforts, involving complexities in cost management, demanding vaccine storage requirements, supply limitations, distribution challenges, absence of a streamlined status collection system, and healthcare system deficiencies.
A systematic review was conducted on the studies that examined the logistical and organizational barriers to HZ vaccination among frail and older adults, aligning with the PRISMA guidelines. Eligibility criteria focus on English studies in Europe, excluding pediatric or irrelevant populations. Rayyan AI was used for data extraction, and bias was assessed using the AXIS tool.
After excluding 841 based on titles and abstracts, 22 publications were selected. A thorough analysis identified 4 studies meeting inclusion criteria, conducted between 2009 and 2022, unveiling several barriers on HZ vaccination: challenges with healthcare professionals, obstacles related to patients' perceptions and knowledge, difficulties in accessibility, structural issues, social dynamics.
The study represents a comprehensive examination, emphasizing the need for targeted interventions to overcome these barriers. The findings underscore the urgency of addressing these challenges to enhance vaccination rates and mitigate the public health burden associated with HZ.
带状疱疹(HZ)对公共卫生构成重大威胁,导致50岁及以上未接种疫苗的成年人发病,偶尔还会导致死亡。全球该年龄组超过95%的人曾接触过水痘-带状疱疹病毒,世界上很大一部分人口易患带状疱疹。如果不接种疫苗,活到85岁的人一生中患带状疱疹的风险为50%。组织和后勤障碍进一步阻碍了疫苗接种工作,涉及成本管理的复杂性、苛刻的疫苗储存要求、供应限制、分发挑战、缺乏简化的状态收集系统以及医疗系统缺陷。
根据PRISMA指南,对研究体弱和老年人带状疱疹疫苗接种的后勤和组织障碍的研究进行了系统综述。纳入标准侧重于欧洲的英文研究,排除儿科或无关人群。使用Rayyan AI进行数据提取,并使用AXIS工具评估偏倚。
根据标题和摘要排除841项研究后,选择了22篇出版物。深入分析确定了2009年至2022年期间进行的4项符合纳入标准的研究,揭示了带状疱疹疫苗接种的几个障碍:医疗保健专业人员面临的挑战、与患者认知和知识相关的障碍、可及性困难、结构问题、社会动态。
该研究是一项全面的调查,强调需要有针对性的干预措施来克服这些障碍。研究结果强调了应对这些挑战以提高疫苗接种率和减轻与带状疱疹相关的公共卫生负担的紧迫性。